Savvy Advisors’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.36M Sell
837,570
-203,095
-20% -$2.03M 0.16% 114
2026
Q2
$10.6M Buy
+1,040,665
New +$9.9M 0.23% 85

Other funds holding VIR

Savvy Advisors's VIR Position: Q3 2026 in Review

Savvy Advisors reduced its Vir Biotechnology (VIR) stake by 20% in Q3 2026, selling an estimated $2.03M and leaving 837,570 shares worth $9.36M. The position accounts for 0.16% of the portfolio, ranked #114.

Savvy Advisors first reported a position in VIR in Q2 2026 and has held it in 2 quarters since. The position peaked at $10.6M in Q2 2026. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Savvy Advisors held 837,570 shares of Vir Biotechnology worth $9.36M as of Q3 2026.
  • Savvy Advisors sold 203,095 Vir Biotechnology shares in Q3 2026, an estimated $2.03M.
  • Vir Biotechnology made up 0.16% of Savvy Advisors's portfolio in Q3 2026, its #114 holding.
  • Savvy Advisors first reported a position in Vir Biotechnology in Q2 2026 and has held it in 2 quarters since.
  • Savvy Advisors's Vir Biotechnology position peaked at $10.6M in Q2 2026.
  • 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Savvy Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.